RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,108,972 | +43.1% | 3,014,568 | +2.9% | 0.00% | +100.0% |
| Q2 2023 | $48,306,284 | +2.3% | 2,929,429 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $47,242,747 | -37.5% | 2,648,136 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $75,604,665 | +38.1% | 2,596,314 | +16.2% | 0.00% | 0.0% |
| Q3 2022 | $54,739,000 | +513.5% | 2,234,272 | +3.9% | 0.00% | – |
| Q2 2022 | $8,922,000 | -65.7% | 2,149,726 | -4.8% | 0.00% | -100.0% |
| Q1 2022 | $26,001,000 | +12.1% | 2,257,020 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $23,188,000 | -23.2% | 2,323,521 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $30,209,000 | -31.7% | 2,313,078 | +2.5% | 0.00% | 0.0% |
| Q2 2021 | $44,200,000 | -7.7% | 2,257,422 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $47,908,000 | -14.5% | 2,252,395 | +19.5% | 0.00% | -50.0% |
| Q4 2020 | $56,056,000 | +36.8% | 1,885,524 | -0.3% | 0.00% | +100.0% |
| Q3 2020 | $40,980,000 | -6.8% | 1,891,038 | -4.1% | 0.00% | -50.0% |
| Q2 2020 | $43,954,000 | +68.8% | 1,971,023 | +15.2% | 0.00% | +100.0% |
| Q1 2020 | $26,039,000 | -32.5% | 1,710,813 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $38,561,000 | +39.6% | 1,679,473 | +31.3% | 0.00% | 0.0% |
| Q3 2019 | $27,620,000 | +5.7% | 1,279,279 | +7.8% | 0.00% | 0.0% |
| Q2 2019 | $26,120,000 | -17.3% | 1,187,260 | +3.1% | 0.00% | 0.0% |
| Q1 2019 | $31,575,000 | +8.5% | 1,151,990 | +6.4% | 0.00% | 0.0% |
| Q4 2018 | $29,096,000 | -4.8% | 1,082,465 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $30,575,000 | +4.8% | 1,048,186 | +12.3% | 0.00% | 0.0% |
| Q2 2018 | $29,166,000 | +263.8% | 933,009 | +131.6% | 0.00% | – |
| Q1 2018 | $8,018,000 | -42.2% | 402,912 | -15.6% | 0.00% | -100.0% |
| Q4 2017 | $13,875,000 | – | 477,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |